Wellington Management Group’s Caribou Biosciences CRBU Stock Holding History

Wellington Management Group’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-523,250	Closed	-$858K	–	1936
2024 Q2	$858K	Buy	523,250 +81,444	+18%	+$260K	﹤0.01%	1707
2024 Q1	$2.27M	Buy	441,806 +127,726	+41%	+$788K	﹤0.01%	1493
2023 Q4	$1.8M	Buy	314,080 +114,975	+58%	+$568K	﹤0.01%	1516
2023 Q3	$952K	Buy	+199,105	New	+$1.24M	﹤0.01%	1619
2023 Q2	–	Sell	-89,224	Closed	-$474K	–	1841
2023 Q1	$474K	Sell	89,224 -472	-0.5%	-$2.94K	﹤0.01%	1846
2022 Q4	$563K	Buy	+89,696	New	+$798K	﹤0.01%	1786

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wellington Management Group's CRBU Position: Q3 2024 in Review

Wellington Management Group sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 523,250 shares — an estimated $858K sold.

Wellington Management Group first reported a position in CRBU in Q4 2022 and held it in 6 quarters. The position peaked at $2.27M in Q1 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

Wellington Management Group reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
Wellington Management Group sold 523,250 Caribou Biosciences shares in Q3 2024, an estimated $858K.
Wellington Management Group first reported a position in Caribou Biosciences in Q4 2022 and held it in 6 quarters.
Wellington Management Group's Caribou Biosciences position peaked at $2.27M in Q1 2024.
129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on Wellington Management Group's 13F filing for Q3 2024, filed 14 Nov 2024.